International Journal of Nutrition and Food Sciences

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

Predictability of Postprandial Lipidemia by Fasting Values in Young Women

For postprandial hyperlipidemia, screening large numbers of subjects by fat-ingestion tests is inconvenient and unrealistic. In the present study, we performed a fat-ingestion test and searched for fasting items to predict postprandial lipidemia. Methods: Healthy young Japanese women (n=54, age 21.1 ± 1.0 y) with apolipoprotein E phenotype 3/3 were enrolled. They ingested fat cream (OFTT cream™, Jomo, Japan; 1 g/kg as cream, 0.35 g/kg as fat). Venous blood samples were taken before (0 h) and at 0.5, 1, 2, 4, and 6 h after ingestion. Results: In multiple regression analyses, the area under the curve (AUC) and the peak of serum triglyceride (TG) were predictable by fasting (f)-TG itself, the AUC of remnant-like particle-TG (RP-TG) was predictable by f-TG and f-RP-TG, the AUC and the peak of remnant lipoprotein-cholesterol (RLP-C) were predictable by f-RLP-C itself, and those of apolipoprotein B-48 (ApoB48) were predictable by f-ApoB48 itself. The AUC and the peak of TG–RP-TG, an index of non-remnant TG, were predictable by f-TG. Conclusion: Postprandial lipidemia may be predictable by the measurement of the set of fasting serum TG, RLP-C, and ApoB48. For daily medical practice, without performing a fat-ingestion test, the set may provide a useful device for predicting postprandial lipidemia.

Predictability, Fat-Ingestion Test, Postprandial Lipidemia, Triglyceride, Remnant Lipoprotein-Cholesterol, Apolipoprotein B-48, Women

Erika Mizutani-Watanabe, Michitaka Naito. (2023). Predictability of Postprandial Lipidemia by Fasting Values in Young Women. International Journal of Nutrition and Food Sciences, 12(5), 116-122.

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License ( which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Zilversmit DB: Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473–485.
2. Takeuchi K, Kazumura K, Kuzawa K, Hatano Y, Nagai M, Naito M: Effect of fat ingestion on postprandial oxidative status in healthy young women: a pilot study. Journal of Clinical Biochemistry and Nutrition 2023 (Advance online publication)
3. Nabeno Y, Fukuchi Y, Matsutani Y, Naito M: Influence of aging and menopause on postprandial lipoprotein responses in healthy adult women. Journal of Atherosclerosis and Thrombosis 2007; 14: 142–150.
4. Mizutani-Watanabe E, Naito M: Remnant indices for estimating postprandial lipidemia in young women. International Journal of Nutrition and Food Sciences 2023; 12: 21–28.
5. Asano M, Fukakura N, Adachi J, Kawaraya C, Nanba A, Yasuda N, Yamamoto E: Use of fast foods among young people. Japanese Journal of Nutrition and Diet 2003; 61: 47–54. (In Japanese).
6. Ichikawa N, Morita Y, Ootani K, Naito M: Effects of co-ingestion of amino acids with fat on postchallenge glycemia and lipidemia in healthy young women. International Journal of Nutrition and Food Sciences 2022; 11: 177–186.
7. Matthews DR, Hosker JR, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
8. Friedewald W, Levy R, Fredrickson D: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972; 18: 499–502.
9. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Campos E, Havel RJ: Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clinica Chimica Acta 1993; 223: 53–71.
10. Miyauchi K, Kayahara N, Ishigami M, Kuwata H, Mori H, Sugiuchi H, Irie T, Tanaka A, Yamashita S, Yamamura T: Development of a homogeneous assay to measure remnant lipoprotein cholesterol. Clinical Chemistry 2007; 53: 2128–2135.
11. Nakatani K, Sugimoto T, Masuda D, Okano R, Oya T, Monden Y, Yamashita T, Kawase R, Nakaoka H, Inagaki M, Yuasa-Kawase M, Tsubakio-Yamamoto K, Ohama T, Nishida M, Ishigami M, Komuro I, Yamashita S: Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels. Atherosclerosis 2011; 218: 226–232.
12. The National Health and Nutrition Survey in Japan, 2019 (In Japanese) (Accessed on July 1, 2023).
13. Couillard C, Bergeron N, Prud’homme D, Bergeron J, Tremblay A, Bouchard C, Mauriège P, Després JP: Postprandial triglyceride response in visceral obesity in men. Diabetes 1998; 47: 953–960.
14. Wideman L, Kaminsky LA, Whaley MH: Postprandial lipemia in obese men with abdominal fat patterning. Journal of Sports Medicine and Physical Fitness 1996; 36: 204–210.
15. Blackburn P, Lamarche B, Couillard C, Pascot A, Bergeron N, Prud’homme D, Tremblay A, Bergeron J, Lemieux I, Després JP: Postprandial hyperlipidemia: another correlate of the “hypertriglyceridemic waist” phenotype in men. Atherosclerosis 2003; 171: 327–336.
16. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM: Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Journal of the American Medical Association 2007; 298: 309–316.
17. Kolovou GD, Watts GF, Mikhailidis DP, Perez-Martinez P, Mora S, Bilianou H, Panotopoulos G, Katsiki N, Ooi TC, Lopez-Miranda J, Tybjærg-Hansen A, Tentolouris N, Nordestgaard BG: Postprandial hypertriglyceridaemia revisited in the era of non-fasting lipid profile testing: a 2019 expert panel statement, main text. Current Vascular Pharmacology 2019; 17: 498–514.
18. Klempfner R, Erez A, Sagit BZ, Goldenberg I, Fisman E, Kopel E; Shlomo N, Israel A, Tenenbaum A: Elevated triglyceride level is independently associated with increased all-cause mortality in patients with established coronary heart disease: twenty-two-year follow-up of the Bezafibrate Infarction Prevention Study and Registry. Circulation-Cardiovascular Quality and Outcomes 2016; 9: 100–108.